gp100:209-217(210 M) peptide vaccine
Jump to navigation
Jump to search
Indications
- investigational use in conjunction with IL-2 for treatment of metastatic melanoma
More general terms
References
- ↑ Schwartzentruber DJ et al. gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma. N Engl J Med 2011 Jun 2; 364:2119 PMID: https://www.ncbi.nlm.nih.gov/pubmed/21631324